Farxiga Lawsuit in 2025: Get the Right Attorney

Farxiga Lawsuit Overview

The Farxiga lawsuit involves claims against AstraZeneca, the manufacturer of Farxiga, for failing to adequately warn patients and doctors about serious, life-threatening side effects associated with the drug.

• Farxiga, a sodium-glucose co-transporter-2 (SGLT2) inhibitor, is used to treat type 2 diabetes but has been linked to severe adverse events.
• Primary allegations include failure to warn, defective design, and negligence in marketing Farxiga.
• Reported injuries include diabetic ketoacidosis, necrotizing fasciitis (Fournier’s gangrene), kidney failure, and heart issues.
• The FDA has issued multiple safety warnings about Farxiga since its 2014 approval, including revised warning labels and safety communications [1].

Latest Farxiga Lawsuit Updates

• May 16, 2024 – A panel of judges established a multidistrict litigation (MDL No. 2776) for all federal product liability lawsuits involving Farxiga and Xigduo XR in the U.S. District Court, Southern District of New York. At least 18 lawsuits alleging kidney damage or diabetic ketoacidosis were consolidated to streamline the pretrial process.
• March 28, 2024 – Lawsuits continue to be filed against AstraZeneca as patients allege Farxiga caused life-threatening complications such as diabetic ketoacidosis, kidney failure, and severe infections. While the previous MDL was closed in 2020, law firms are still actively investigating and accepting new cases nationwide.
• March 1, 2024 – AstraZeneca, the manufacturer of Farxiga, faced a federal lawsuit challenging the inclusion of Farxiga in Medicare’s drug price negotiation program. Although the judge dismissed AstraZeneca’s claim, the case reflects ongoing legal battles affecting Farxiga’s market status.
• April 13, 2017 – A panel of judges has agreed to establish a multidistrict litigation (MDL) for all federal product liability lawsuits involving the type 2 diabetes medications Farxiga and Xigduo XR in the U.S. District Court, Southern District of New York. According to a Transfer Order (PDF) issued Thursday, at least 18 lawsuits alleging kidney damage or diabetic ketoacidosis from Farxiga or Xigduo XR have been filed in federal courts across the U.S.
• October 16, 2015 – As claimed by Bloomberg News, AstraZeneca Plc failed to win U.S. approval for a new diabetes medication that combines dapagliflozin (the active ingredient in Farxiga) and saxagliptin (the active ingredient in Onglyza) after regulators asked for additional data that may require new clinical trials.

FDA Reports and Statistics

FDA adverse event reports show a substantial number of serious complications associated with Farxiga use:

• At least 80 cases of diabetic ketoacidosis were reported in a 12-month period (July 2014-June 2015).
• 101 confirmed cases of acute kidney injury were reported between March 2013 and October 2015.
• Multiple severe urinary tract infections requiring hospitalization.
• The FDA continues to monitor and issue updated safety communications about Farxiga risks.

In addition to Farxiga, other type 2 diabetes medications in the SGLT2 inhibitor class include:

• Invokamet
• Jardiance (empagliflozin)
• Glyxambi (empagliflozin and linagliptin)
• Xigduo XR (dapagliflozin and metformin extended-release)

Farxiga Injuries & Side Effects

Farxiga has been linked to numerous serious and potentially life-threatening side effects:

• Diabetic ketoacidosis (DKA): A life-threatening condition where excess acids (ketones) build up in the blood
• Kidney failure: Acute kidney injury requiring hospitalization
• Heart attack: Increased risk of myocardial infarction
• Severe UTIs: Serious urinary tract infections that may lead to hospitalization
• Bone fractures: Increased risk of bone fragility and breaks
• Low blood sugar: Hypoglycemia requiring medical intervention
• Genital infections: Severe yeast infections affecting quality of life

See all related dangerous drug lawsuits our attorneys covered so far.

Do You Qualify for a Farxiga Lawsuit?

You may qualify for a Farxiga lawsuit if:

• You were prescribed and took Farxiga or Xigduo XR (dapagliflozin)
• You experienced serious side effects such as diabetic ketoacidosis, kidney failure, heart attack, or severe UTI
• Your injuries required medical treatment or hospitalization
• You can provide medical documentation linking your injuries to Farxiga use

Evidence Required for a Farxiga Lawsuit

To build a strong case, you’ll need:

• Medical records documenting your Farxiga prescription
• Hospital and treatment records for your injuries
• Lab test results showing ketoacidosis, kidney damage, or other complications
• Documentation of your diabetes diagnosis and treatment history
• Proof of proper usage according to your doctor’s instructions

Damages You Can Recover

A successful Farxiga lawsuit may provide compensation for:

• Past and future medical expenses
• Lost wages and reduced earning capacity
• Pain and suffering
• Emotional distress
• Permanent disability or impairment
• Punitive damages against the manufacturer

Statute of Limitations for Farxiga Lawsuits

Time limits for filing a Farxiga lawsuit vary by state, typically ranging from 1-3 years from the date you discovered your injury was related to the medication. Don’t delay seeking legal advice, as waiting too long could bar you from recovery.

FAQs

1. What Is Diabetic Ketoacidosis, and How Is It Linked to Farxiga Use?

Diabetic ketoacidosis (DKA) is a severe condition where the body produces excess acids (ketones). Farxiga use has been linked to increased DKA risk, especially in type 2 diabetics.

2. What Should Patients Know about the FDA Warnings Regarding Farxiga?

The FDA has issued warnings about Farxiga, highlighting the risks of diabetic ketoacidosis, severe urinary tract infections, and kidney injury. Patients should be aware and monitor symptoms closely.

3. How Does Farxiga Compare to Other SGLT2 Inhibitors in Terms of Risks?

Farxiga shares similar risks with other SGLT2 inhibitors, including DKA, kidney injury, and infections, but each drug’s specific side effect profile may vary slightly based on individual patient response.

4. Has the FDA Recalled Farxiga?

No, Farxiga has not been recalled, but the FDA has issued multiple safety communications and required label updates warning about serious risks including ketoacidosis, kidney injuries, and severe UTIs.

5. What Compensation Might I Receive from a Farxiga Lawsuit?

Compensation may include coverage for medical expenses, lost wages, pain and suffering, emotional distress, and in some cases, punitive damages against the manufacturer.

6. How Much Does It Cost to File a Farxiga Lawsuit?

At Schmidt&Clark, we work on a contingency fee basis, meaning you pay nothing unless we win your case. Initial consultations are free and confidential.

Take Action Now: Time-Sensitive Legal Claims

Time is limited to pursue legal action for Farxiga-related injuries. Most states only allow 1-3 years from the date of injury discovery to file a claim.

Our experienced pharmaceutical litigation team at Schmidt & Clark, LLP is ready to help you:

• Free, confidential consultation to evaluate your case
• No upfront costs or legal fees
• Payment only if we win your case
• Nationwide representation for Farxiga victims

Don’t wait until it’s too late to seek justice and compensation for your suffering.

References:

1. https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious